NYQ·Healthcare·$1.1B·#178 / 520 in Healthcare
CNMD CONMED Corporation
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH8
QUALITY62
STABILITY76
VALUATION100
GOVERNANCE36
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+5.2%
8
> 50% strong
Gross Margin
Revenue retained after direct costs
54.6%
77
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
80.8%
27
< 25% strong
Price / Sales
Market cap relative to trailing revenue
0.8x
100
< 3x strong
Rule of 40
Growth rate plus operating margin
13
39
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.4%
3
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-3.7%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CNMD WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CNMD's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.